---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-038037"
form_type: "8-K"
ticker: "NKTX"
cik: "0001787400"
company_name: "Nkarta, Inc."
filed_at: "2024-03-28T23:59:59+00:00"
generated_at: "2026-06-04T06:23:25.381140+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nkarta raises ~$225.2M in underwritten offering of stock and pre-funded warrants

## Summary
- Offering of 21,010,000 shares at $10.00 and pre-funded warrants for 3,000,031 shares at $9.9999.
- Net proceeds of ~$225.2M after underwriting discounts and estimated expenses.
- Proceeds to fund NKX019 clinical development and internal manufacturing buildout.
- Pre-funded warrants exercisable immediately at $0.0001 per share, with 19.99% ownership cap.
- Underwriting agreement with Leerink Partners and Cowen and Company, LLC, dated March 25, 2024.

## SEC filing metadata
- accession: 0000950170-24-038037
- form_type: 8-K
- ticker: NKTX
- cik: 0001787400
- company_name: Nkarta, Inc.
- filed_at: 2024-03-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787400/000095017024038037/0000950170-24-038037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787400/000095017024038037/nktx-20240325.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-038037
- JSON: https://secwatch.observer/filing/0000950170-24-038037.json
- Plain text: https://secwatch.observer/filing/0000950170-24-038037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.